Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Quantitative immunohistology: tissue section thickness, another glitch in the path to standardization.

Leong AS.

Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):465-9. doi: 10.1097/PAI.0b013e3181a60898. No abstract available.

PMID:
19602967
2.

Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers.

O'Hurley G, Sjöstedt E, Rahman A, Li B, Kampf C, Pontén F, Gallagher WM, Lindskog C.

Mol Oncol. 2014 Jun;8(4):783-98. doi: 10.1016/j.molonc.2014.03.008. Epub 2014 Mar 21. Review.

3.

The use of immunohistochemistry for biomarker assessment--can it compete with other technologies?

Dunstan RW, Wharton KA Jr, Quigley C, Lowe A.

Toxicol Pathol. 2011 Oct;39(6):988-1002. doi: 10.1177/0192623311419163. Erratum in: Toxicol Pathol. 2012;40(1):127.

PMID:
21971934
4.

[Issues related to standardization of immunohistochemistry].

Liu TH.

Zhonghua Bing Li Xue Za Zhi. 2008 Dec;37(12):793-4. Chinese. No abstract available.

PMID:
19159520
5.

A reference image-based method for optimization of clinical immunohistochemistry.

Kap M, Lam KH, Ewing-Graham P, Riegman P.

Histopathology. 2015 Aug;67(2):193-205. doi: 10.1111/his.12646. Epub 2015 Feb 19.

PMID:
25640638
6.

Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.

Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu EB, Swanson PE, Taylor CR, Vyberg M; International Ad Hoc Expert Panel.

Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):241-52. doi: 10.1097/PAI.0000000000000069.

7.
8.

Computer-aided techniques for chromogenic immunohistochemistry: status and directions.

Di Cataldo S, Ficarra E, Macii E.

Comput Biol Med. 2012 Oct;42(10):1012-25. doi: 10.1016/j.compbiomed.2012.08.004. Epub 2012 Sep 13. Review.

PMID:
22980752
9.

Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.

Yaziji H, Taylor CR, Goldstein NS, Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S, Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks DG; Members of the Standardization Ad-Hoc Consensus Committee.

Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):513-20. doi: 10.1097/PAI.0b013e31818a9d3a.

PMID:
18931614
10.

HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.

Wludarski SC, Lopes LF, Berto E Silva TR, Carvalho FM, Weiss LM, Bacchi CE.

Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):112-8. doi: 10.1097/PAI.0b013e3181f0b044.

PMID:
20930616
11.

Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.

Rojo MG, Bueno G, Slodkowska J.

Folia Histochem Cytobiol. 2009 Jan;47(3):349-54. doi: 10.2478/v10042-008-0114-4. Review.

12.

Analytic variability in immunohistochemistry biomarker studies.

Anagnostou VK, Welsh AW, Giltnane JM, Siddiqui S, Liceaga C, Gustavson M, Syrigos KN, Reiter JL, Rimm DL.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):982-91. doi: 10.1158/1055-9965.EPI-10-0097. Epub 2010 Mar 23.

13.

Nondestructive quality control of HER2 control cell line sections: the use of interferometry for measuring section thickness and implications for HER2 interpretation on breast tissue.

Barker C, Ibrahim M, Miller K, Reid V.

Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):536-42. doi: 10.1097/PAI.0b013e3181a31bfc.

PMID:
19417622
14.

Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.

Taylor CR, Levenson RM.

Histopathology. 2006 Oct;49(4):411-24. Review.

PMID:
16978205
15.

Fine-needle cytopuncture and flow cytometry in the characterization of human tumors.

Spyratos F, Briffod M.

Methods Cell Biol. 1994;42 Pt B:177-92. No abstract available.

PMID:
7533239
16.

Interpretation and quantification of immunostains.

Seidal T, Balaton AJ, Battifora H.

Am J Surg Pathol. 2001 Sep;25(9):1204-7. Review.

PMID:
11688582
17.
18.

Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.

Micsik T, Kiszler G, Szabó D, Krecsák L, Hegedűs C, Tibor K, Molnár B.

Pathol Oncol Res. 2015 Sep;21(4):1005-11. doi: 10.1007/s12253-015-9927-6. Epub 2015 Mar 19.

PMID:
25788005
19.

Quantitative assessment of relative changes of immunohistochemical staining by light microscopy in specified anatomical regions.

Paizs M, Engelhardt JI, Siklós L.

J Microsc. 2009 Apr;234(1):103-12. doi: 10.1111/j.1365-2818.2009.03146.x.

20.

Towards credible immunocytochemical findings.

Vielh P.

Cytopathology. 2011 Aug;22(4):213-4. doi: 10.1111/j.1365-2303.2011.00892.x. No abstract available.

PMID:
21771091

Supplemental Content

Support Center